The transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently activated in human cancers. Interestingly, STAT3 also maintains the pluripotency and self-renewal of murine embryonic stem cells, and several tissue stem cell types. To investigate whether STAT3 also maintains the small-intestine crypt stem cell, we conditionally inactivated a Floxed Stat3 allele (Stat3 fl ) in murine small-intestine crypt stem cells. Following Cre recombinase expression, apoptosis increased in Stat3 fl/À experimental crypts relative to Stat3 wt/À controls before declining. Control Stat3 wt/À mice carrying a Flox-STOP LacZ reporter transgene stably expressed LacZ after Cre induction. In contrast, Stat3 fl/À intestine LacZ expression initially increased modestly, before declining to background levels. Quantitative PCRs revealed a similar transient in recombined Stat3 fl allele levels. Long-term bromodeoxyuridine labelling directly demonstrated that functional STAT3 is required for þ 4 to þ 6 region label-retaining small-intestine stem cell survival. Rapid clearance of recombined Stat3 fl/À cells involves apoptosis potentially induced by elevated c-Myc in non-recombined cells and involves elevated p53 expression and caspase 3 activation. Intriguingly, Stat3 fl/À intestine recombination triggered dramatically upregulated polycomb transcriptional repressor Bmi1 -potentially accelerating recombined crypt repopulation. In summary, STAT3 activity is absolutely required for small-intestine crypt stem cell survival at both the þ 4 to þ 6 label-retaining and crypt base columnar cell locations. Cell Death and Differentiation (2011) 18, [1934] [1935] [1936] [1937] [1938] [1939] [1940] [1941] [1942] [1943] ; doi:10.1038/cdd.2011.77; published online 3 June 2011
The signal transducer and activator of transcription (STAT) family of transcription factors are activated in response to extracellular cytokine and growth factor ligands. Classically, following phosphorylation at a single-tyrosine residue by JAK family tyrosine kinases, STAT monomers dimerise via reciprocal phosphotyrosine-Src homology 2 (SH2) domain interactions, acquiring nuclear localisation activity and highaffinity DNA-binding activity to activate gene expression. 1, 2 Inappropriate activation of STAT family members, especially STAT3, occurs in numerous human cancers and cancer cell lines.
3,4 STAT3 activation is also critical for maintaining pluripotency and preventing differentiation of murine embryonic stem (mES) cells. Thus, inducible expression of a dominant negative interfering STAT3F mutant in mES cells abolished their self-renewal and promoted differentiation. 5 STAT3 function is also important in several tissue stem cell types -for example, porcine skin stem cells express STAT3 at high levels. 6 Similarly, transduction of murine haematopoietic stem cells with a dominant negative STAT3-expressing retrovirus caused a large and permanent reduction in their in vivo lympho-myeloid reconstituting ability. 7 Here, we examine the requirement of murine small-intestine crypt stem cells for functional STAT3. The small-intestine epithelium undergoes constant renewal -a process dependent upon stem cells located near the crypt base. 8 The crypt stem cells generate a population of rapidly proliferating cellsthe transit-amplifying cells -which undergo a limited number of divisions while migrating up the crypt. On reaching the crypt-villus junction, these transit-amplifying cells exit the cell cycle and terminally differentiate, yielding mature enterocytes, goblet cells and enteroendocrine cells, which migrate towards and eventually shed from, the villus tip. The crypt base, in contrast, comprises two other cell types -Paneth cells and slowly proliferating crypt base columnar (CBC) cells. The precise identity of the small-intestine crypt stem cell has been controversial for many years, with one long-accepted candidate being the radiation-hypersensitive, long-term labelretaining cell located at the þ 4 to þ 6 positions from the crypt base. 9 Another long-time crypt stem cell candidate, the CBC cell interleaved between crypt base Paneth cells 10 has attracted renewed interest following studies demonstrating that Lgr5-expressing CBC cells can regenerate all the cell types in the small-intestine crypt-villus unit, 11 and indeed, can generate crypt-like structures in vitro with self-renewal activity. 12 Given the importance of aberrantly activated STAT3 in many cancers, the resurgent interest in the cancer stem cell concept as a therapeutic target, and the importance of STAT3 function in mES and several tissue stem cell types, we investigated STAT3's role in the murine small-intestine crypt.
We used an inducible cytochrome P450 Cyp1A1 promoterCre recombinase (AH-Cre) transgene 13 and a Stat3 allele carrying LoxP sites flanking the exon encoding STAT3's tyrosine 705 residue (Stat3 fl ) 14 to conditionally inactivate STAT3 in murine small-intestine crypts in response to treatment with the xenobiotic b-naphthoflavone. The inducible AH-Cre transgene allows Cre expression in both the CBC crypt stem cells and in the þ 4 to þ 6 position long-term labelretaining crypt stem cells. 15 The second Stat3 allele in both control and experimental mice was a Null(À) allele whose exons encoding the SH2 domain and the tyrosine 705 residue have been removed -yielding a STAT3 protein which cannot undergo dimerisation. 16 In this study, we provide evidence that STAT3 function is necessary for the survival of both the murine small-intestine crypt þ 4 to þ 6 position long-term label-retaining stem cell and the slowly proliferating CBC stem cell.
Results
Use of a Flox-STOP LacZ transgene reveals the transient appearance and subsequent loss of STAT3-null crypts. The Flox-STOP LacZ reporter transgene was used as a surrogate marker of recombined small-intestine crypts. By 1 day after the induction of Cre expression, the control Stat3 wt/À small intestine expressed LacZ activity at medium level, whereas the experimental Stat3 fl/À intestine expressed low levels of LacZ activity. By 2 days post induction, the control Stat3 wt/À intestine showed homogeneous high-level LacZ activity, whereas the experimental Stat3 fl/À intestine showed only a modest rise in LacZ activity. By 3 days post induction, the control intestine retained high-level LacZ expression as expected. In contrast, the Stat3 fl/À intestine showed essentially no macroscopically observable LacZ activity ( Figure 1a ). Cross-sections of day 3 experimental and control small intestines demonstrated LacZ staining consistent with Cre-recombined Flox-STOP LacZ cells migrating out of the crypt (Figure 1b) . Stripping away the smooth muscle layer allowed direct examination of the smallintestine crypt bases. By 3 days post induction, virtually 100% of Stat3 wt/À crypt bases had strong LacZ staining, reflecting the continued viability of the Stat3 wt/À crypt stem cell(s). In contrast, in the Stat3 fl/À experimental intestine, virtually none of the crypt bases retained any LacZ staining activity (Figure 1c) .
To confirm that the Stat3 fl/À small intestine was functionally STAT3 null following Cre induction, anti-STAT3 immunohistochemistry was performed using the New England Biolabs/ Cell Signaling Technology #9132 (NEB/CST#9132; NEB/ CST, Ipswich, MA, USA) antibody (recognising an epitope around the STAT3 tyrosine 705 residue) -this revealed a loss of STAT3 immunoreactivity from the Stat3 fl/À small-intestine crypts by 1.7 days post induction relative to the Stat3 wt/À control ( Figure 1d ). To confirm that STAT3 is constitutively activated in the crypt epithelium, immunohistochemistry was performed using the NEB/CST #9131 antibody, which recognises tyrosine 705 phosphorylated STAT3. This revealed frequent, strong, nuclear phosphotyrosine 705 immunoreactivity in un-induced Stat3 wt/À control crypt epithelial Elevated c-Myc and p53 expression implicated in the apoptotic removal of Cre-recombined Stat3 fl/À crypt cells. We also demonstrate statistically significantly Figure 6 Long-term BrdU labelling of Stat3 fl/À and Stat3 wt/À small-intestine crypts demonstrating the loss of BrdU-labelled þ 4 to þ 6 crypt cells in response to STAT3 inactivation. Stat3 fl/À and Stat3 wt/À mice were given BrdU in their drinking water for 3 weeks, followed by an 8-week water-only chase phase. This was followed by b-naphthoflavone injection and induction of Cre recombinase expression with a 7 day delay before harvesting. Small-intestine samples were then analysed by anti-BrdU immunohistochemistry and all BrdU-positive, nonPaneth, nuclei identified. The BrdU-positive cells were then divided up into three groups -crypt base positions þ 1 to þ 3 (base), the þ 4 to þ 6 positions ( þ 4 to þ 6) and crypt positions from þ 7 to the crypt-villus junction (higher). To directly demonstrate that STAT3 inactivation in a crypt epithelial cell can lead to the apoptosis of that cell, we performed confocal fluorescent immunohistochemistry on serial small-intestine tissue sections using an anti-activated caspase 3 antibody combined with a 4 0 ,6-diamidino-2-phenylindole (DAPI) nuclear counterstain versus, on alternating slides, the NEB/ CST #9132 anti-STAT3 antibody, again combined with a DAPI counterstain. This demonstrated the presence in day 2 Cre-recombined Stat3 fl/À crypts of epithelial cells, which showed essentially no detectable STAT3 but which displayed clear activated caspase 3 immunoreactivity (Figure 9 ).
Elevated Bmi1 in the recombined Stat3
fl/À crypt as a possible mechanism to accelerate crypt repopulation. It has been suggested that the polycomb transcriptional repressor family member Bmi1 marks the small-intestine crypt þ 4 to þ 6 region stem cell, with expression at the þ 4 and þ 5 positions up from the crypt base. 19 Hence, we performed anti-Bmi1 immunohistochemistry on Stat3 fl/À and Stat3 wt/À small intestine. In contrast to the expected obvious Bmi1 immunoreactivity at the þ 4 and þ 5 positions in Stat3 wt/À crypts, there was a generally very low frequency of Bmi1-positive nuclei, which were usually found in the lower half of the crypt. In contrast, there was a very obvious significant increase in the frequency of strongly Bmi1-positive nuclei throughout the crypt in 
Discussion
This study demonstrates the requirement for functional STAT3 in the crypt stem cells of the murine small intestine, with recombined Stat3 fl/À crypt stem cells being rapidly eliminated and the intestinal epithelium being repopulated with cells retaining functional STAT3.
The AH-Cre transgene allows Cre expression in both smallintestine crypt stem cell compartments -the þ 4 to þ 6 position long-term label-retaining master stem cells, and the proliferating, non-label-retaining, Lgr5
þ CBC stem cells driving tissue homeostasis. The þ 5 to þ 6 location of the initial burst of apoptosis seen in the Stat3 fl/À crypt relative to the Stat3 wt/À crypt at day 1.7 following induction of Cre expression corresponds well with the location of the þ 4 to þ 6 label-retaining quiescent master stem cell. Whereas by day 2 following Cre induction, the elevated apoptotic index in the Stat3 fl/À crypt is also clear at lower positions in the crypt. This might reflect two separate events -an initial recombination-driven apoptotic pulse by day 1.7 in the Stat3 fl/À þ 4 to þ 6 master stem cells, followed at around day 2 by a wave of functionally STAT3-null cells generated from the recombined The failure to observe obvious anti-Bmi1 immunoreactivity at the þ 4 and þ 5 positions in the Stat3 wt/À crypt base (in the expectation of reduced immunoreactivity following Stat3 fl/À crypt recombination) was unexpected. Instead, there was a massive upregulation of strong anti-Bmi1 immunoreactivity in the Stat3 fl/À crypt at 2-3 days following Cre induction. One explanation for the upregulated crypt Bmi1 expression following STAT3 inactivation might lie in a recent study of a murine ES cell chromatin remodelling complex, esBAF, critical for maintaining ES cell pluripotency and self-renewal. 20 Chromatin immunoprecipitation-sequencing demonstrated a highly statistically significant 70% co-occupation of murine ES cell target genes by both STAT3 and the esBAF ATPase component Brg. Further, knocking-down Brg expression upregulated the expression of several polycomb group (PcG) genesincluding Bmi1, Cbx7 and Ring1a -which normally contribute to the polycomb repressive complex 1. These genes also contained a statistically significant region bound by Brg, with the suggestion that esBAF/Brg normally antagonises PcG function in murine ES cells by binding to and repressing PcG gene transcription. In a striking parallel with Brg knockdown in murine ES cells, STAT3 inactivation in the small-intestine crypt also upregulated Bmi1 expression, implying that the frequent co-occupation of murine ES cell target genes by STAT3 and esBAF/Brg is functionally important -with a potentially analogous interaction in the crypt stem cell(s).
In contrast, several PcG subunit genes were not upregulated following Brg knockdown, these included Suz12, Eed and Ezh2, encoding Polycomb repressive complex 2 components. 20 Interestingly, the Eed gene is transcriptionally controlled by STAT3 (and Oct4) in murine ES cells, with STAT3/Oct4 (via Eed) reversibly silencing differentiationassociated genes such as Tbx5, GATA6 and Cdx2. 21 Further, Eed and Bmi1 can function antagonistically -in haematopoietic cell proliferation, Eed demonstrated an anti-proliferative function, negatively regulating lymphoid and myeloid progenitor cell numbers in the bone marrow, 22 whereas Bmi1 positively regulated primitive bone marrow progenitor cell proliferation. 22 Thus, one model for STAT3 function in the murine smallintestine crypt stem cell(s) could involve an interaction between STAT3 and a stem cell chromatin remodelling complex to bind to the Bmi1 gene, suppressing Bmi1 expression and restraining crypt stem cell proliferation. In addition, STAT3 could drive Eed gene expression, again downregulating crypt stem cell proliferation. STAT3 inactivation would impair both of these potential mechanisms to restrain crypt stem cell proliferation. The STAT3-null crypt stem cells would then exit the pluripotent/self-renewing state, proliferate, and be removed through apoptosis, accelerating the repopulation of the recombined Stat3 fl/À small intestine.
Materials and Methods
Generation of mouse strains. Mice carrying the Floxed(fl) and Null(À) Stat3 alleles were the kind gift of Professor S Akira, 14, 16 whereas mice carrying the AH-Cre transgene were the kind gift of Dr. DJ Winton. 13 Mice used in this study were outbred, segregating for the C57BL6/J 129/Ola and C3H genomes, with littermates being used as controls. Murine genomic DNA was isolated using a commercial DNA purification kit (5 Prime GmbH, Hamburg, Germany) and genotyped by PCR using primers which are specific for the Stat3 wt versus fl alleles, for the Stat3 À allele and the Cre and LacZ transgenes. The following oligodeoxynucleotide primer pairs were used for PCR genotyping: 5 0 -CCTGAAGACCAAGTTCATCTGTGTGAC-3 0 and 5 0 -CA CACAAGCCATCAAACTCTGGTCTCC-3 0 yields an B320-bp PCR product for the Stat3 fl allele versus an B230-bp PCR product for the Stat3 wt allele. For the Stat3 Null(À) allele PCR reaction, primers 5 0 -AGCAGCTGACAACGCTGGCTGAGAAG CT-3 0 and 5 0 -ATCGCCTTCTATCGCCTTCTTGACGA-3 0 yield an B1-kbp PCR product. For the combined PCR reaction for Cre and LacZ transgenes, the 5 0 -TGA CCGTACACCAAAATTTG-3 0 and 5 0 -ATTGCCCCTGTTTCACTATC-3 0 primer pair yields an B1-kbp PCR product for the Cre transgene and the 5 0 -CTGGCGTTAC CCAACTTAAT-3 0 and 5 0 -ATAACTGCCGTCACTCCAAC-3 0 primer pair yields an B500-bp PCR product for the LacZ transgene. All mice used in this study were male, between 3 and 6 months old (with the exception of Supplementary Figure S1) , with three or more mice per time point for both genotypes, and were cared for in accordance with UK Home Office guidelines.
Induction of recombination and harvesting experimental and control mice. To induce Cre recombinase expression, male mice were injected intraperitoneally with a 10 mg/ml b-naphthoflavone (Sigma, St. Louis, MO, USA) solution in corn oil (Sigma) to give a final b-naphthoflavone dose of 100 mg per kg body weight. Three intraperitoneal injections were administered in 1 day with injections spaced 2 h apart for the 1, 1.7 and 2 day time points and 3-4 h apart for the 3 and 4 day time points, all mice were harvested in the afternoon. After harvesting, the first 8 cm of small intestine and the final remaining bulk part of the small intestine were transferred into methacarn fixative (4 : 2 : 1 volumes methanol : chloroform : glacial acetic acid) overnight before transfer to neutralbuffered formalin (Sigma) and tissue processing. The intervening section of small intestine was divided into samples for overnight fixation in cold formalin and paraffin embedding for immunohistochemistry (quick fixed), and for genomic DNA extraction.
Long-term BrdU label-retention experiment. For long-term BrdU labelretention experiments, mice were given BrdU (Sigma) dissolved in their drinking water at 3 mg/ml for 3 weeks, followed by an 8 week chase period with water alone. Mice were then given three 100 mg/kg b-naphthoflavone (in corn oil) intraperitoneal injections 4 h apart to induce Cre recombinase expression and harvested 7 days later. Following harvesting, small-intestine samples were quick fixed and then subjected to anti-BrdU immunohistochemistry, brief haematoxylin counterstaining and extended eosin staining. All well-formed crypts were counted and any nuclei showing BrdU immunoreactivity were identified, with any BrdU-positive cells showing histochemical or morphological features of Paneth cells being discounted.
LacZ staining of small intestine. For LacZ staining, small intestines were harvested, flushed through with ice-cold phosphate-buffered saline (PBS; Invitrogen, Carlsbad, CA, USA) and then flushed through with ice-cold X-gal fixative solution (0.5 volumes formalin, 0.5 volumes PBS, 0.004 volumes 25% glutaraldehyde (wt/vol) (Sigma) solution). Sections of small intestine were then cut open, pinned flat and lumen-uppermost on a paraffin wax-filled Petri dish and fixed for 1 h in X-gal fixative, then washed with PBS and incubated with demucifying solution (10% (vol/vol) glycerol, 10 mM Tris-HCl pH8.2, 20% (vol/vol) ethanol, 92 mM NaCl, 22 mM dithiothreitol) for 1 h. Subsequently, the intestine was washed with PBS and any adhering mucus removed. The dish was then incubated overnight in the dark with gentle agitation with X-gal staining solution (0.004 volumes of 5% (wt/vol) X-gal in dimethylformamide (Promega, Madison, WI, USA) in 10 mM MgCl 2 , 29 mM potassium ferricyanide, 30 mM potassium ferrocyanide in PBS). Finally, the X-gal staining solution was discarded and the intestine washed with PBS and formalin.
Measurements of apoptotic and mitotic indices in murine small intestine. For measurements of apoptotic and mitotic indices in the crypts of the small intestine, methacarn-fixed small-intestine slides were stained with H þ E (RA Lamb, Thermofisher Scientific, Waltham, MA, USA). Apoptotic and mitotic cells were identified by their characteristic morphologies with each individual cell position within 56 half-crypts being assessed and counted to yield apoptotic and mitotic indices at each individual position within the crypt. These individual crypt position frequencies were then summed to yield overall crypt apoptotic and mitotic indices.
Immunohistochemistry. STAT3 immunohistochemistry used a primary antibody (NEB/CST #9132) recognising an epitope close to the STAT3 tyrosine 705 residue. Antigen retrieval used heating slides in 1 Â citrate buffer (LabVision, Thermofisher Scientific). The primary rabbit anti-STAT3 antibody NEB/CST #9132 was diluted 1 : 100 in 5% normal goat serum (NGS (vol/vol); Dako, Glostrup, Denmark) in 1 Â Tris-buffered saline (TBS; Sigma). The secondary antibody step used anti-rabbit horseradish peroxidase (HRP)-labelled polymer (EnVision þ , Dako). HRP activity was then visualised with a 3,3 0 -diaminobenzidine (DAB) chromogenic substrate system (EnVision þ , Dako), DAB staining used a 10 min development time.
STAT3 phosphotyrosine 705 immunohistochemistry used the NEB/CST #9131 primary antibody. Antigen retrieval used heating slides in 1 Â EDTA buffer (LabVision). The primary rabbit anti-phosphotyrosine 705 STAT3 antibody (NEB/ CST #9131) was diluted 1 : 100 in 5% NGS (vol/vol) in 1 Â TBS, 0.1% (vol/vol) Tween-20 (Sigma; TBS/T). The secondary antibody step used anti-rabbit HRPlabelled polymer (EnVision þ , Dako), DAB (Dako) staining used a 10 min development time. 
